Prospective Open-Label Trial of Etanercept as Adjunctive Therapy for Kawasaki Disease - Choueiter, Nadine F.; Olson, Aaron K.; Shen, Danny D.; Portman, Michael A. (The Journal of pediatrics, 2010)
Keywords: Biological and medical sciences; Child, Preschool; Etanercept; Female; General aspects; Humans; Immunoglobulin G - therapeutic use; Infant; Male; Medical sciences; Mucocutaneous Lymph Node Syndrome - drug therapy; Pediatrics; Prospective Studies; Receptors, Tumor Necrosis Factor - antagonists & inhibitors; Receptors, Tumor Necrosis Factor - therapeutic use; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis; AAP; CRP; RCA; JIA; TNF-α; IVIG; KD; AHA; LAD; TB; C-reactive protein; Left anterior descending; Tumor necrosis factor –α; Intravenous immunoglobulin; American Academy of Pediatrics; Juvenile idiopathic arthritis; American Heart Association; Right coronary artery; Kawasaki disease; Tuberculosis; Kawasaki syndrome; Drug; Immunopathology; Pediatrics; Cytokine; Antipsoriatic agent; Adjuvant treatment; Autoimmune disease; Cardiovascular disease; Anti-Tumor Necrosis Factor-alpha; Vascular disease; Immunomodulator; Prospective; Vasculitis; Etanercept; Anticytokine; Systemic disease; Clinical trial; Antagonist; Antirheumatic agent; Fusion protein; Tumor necrosis factor α